GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.
UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...
The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...
The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.
The U.S. health regulator has approved GSK's add-on drug to treat severe asthma, the drugmaker said on Tuesday, paving the ...
Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.
6don MSN
Switch off your allergies for years without daily pills? Know the treatment backed by WHO and AAAAI
Allergy shots and drops offer a transformative solution for millions. Major health organisations globally endorse this ...
A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...
Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...
Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...
In this video, Jonathan A. Bernstein, MD, discusses his American College of Allergy, Asthma & Immunology Annual Scientific ...
In this video, Gailen D. Marshall Jr., MD, PhD, chair of allergy and immunology at University of Mississippi Medical Center, discusses the clinical development of the nanobody compound lunsekimig for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback